Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events

NCT01572909 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Reperfusion Injury
STEMI

Interventions

DRUG: Bendavia (MTP-131)
DRUG: Placebo

Sponsor

Stealth BioTherapeutics Inc.

Collaborators

[object Object]